Home » Newsletters » BioWorld Science

BioWorld Science

May 18, 2005

View Archived Issues

Astressin-2B reduces enterotoxin-mediated inflammatory processes

SLV-317 exerts antiinflammatory effects in experimental ileitis and colitis

Chugai reports domestic and overseas progress

Updated results for Genasense in CLL

Animal data on SP-304

Bionomics receives grant extension for CNS drug development

Talotrexin enters new phase I/II study for ALL

New phase Ib/II study of ADH-1

Mera and Rincon announce protein expression system research collaboration

Sorafenib plus chemotherapy studied in new phase III trial

Low incidence of anemia found with viramidine plus peginterferon alfa-2a in hepatitis C patients

Good safety profile found for multiple doses of VX-950 in healthy subjects

New data on the safety and pharmacokinetics of CpG-10101 in hepatitis C

SCR-011, a therapeutic candidate for ocular neovascularization

MB-500 promotes corneal wound healing

Antisense hTERT shows potential as a gastric cancer therapy

Amarillo receives SBIR grant for H. pylori vaccine development work

New stem cell trial to begin in heart failure patients

Piperazine derivative shows anxiolytic and antidepressant activity in preclinical studies

Novel benzodiazepine derivatives possess prolonged anticonvulsant properties

Recent patents disclose novel therapeutic agents for cancer

Remicade approved for psoriatic arthritis

Traditional approval for Trizivir

Novel SERMs emerge from GlaxoSmithKline research

Vertex patents voltage-gated sodium channel inhibitors for treatment of pain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...